Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs Xcel Energy Inc (XEL) Price & Performance

Nuwellis IncTrade
Xcel Energy IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs Xcel Energy Inc — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Xcel Energy Inc trades at $73.36 (market cap $45.82B). The key difference: Xcel Energy Inc is far larger — about 20827.3× Nuwellis Inc's market cap, and Xcel Energy Inc pays a 3.23% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Xcel Energy Inc for 61 Days on average.

NUWEXEL
Market Cap
$2.20M$45.82B
Volume
121,5446,910,516
Sector
HealthUtilities
52-Week High
$146.65$83.91
52-Week Low
$0.68$69.39
Typical Hold Time
26 Days61 Days
Enterprise Value
-$1.52M$84.14B
Dividend Yield
—3.23%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Xcel Energy Inc

Xcel Energy (XEL) trades at $72.42, down 0.43% with bearish technical signals despite recent earnings beats. The stock shows solid fundamentals with $14.67B revenue, 15.28% net margin, and consistent dividend payments. Analyst consensus remains bullish with a $90.83 price target, though technical indicators show RSI overbought conditions and bearish moving average signals. Recent news highlights growth from data center power demand and infrastructure investments.

XEL offers steady utility exposure with 62.96% analyst buy ratings and 3.3% dividend yield. Key opportunities include $60B capex plan and data center demand growth, while risks involve wildfire liabilities, rising debt levels, and regulatory pressures. The stock trades at reasonable valuations (P/E 19.84) with potential 25% upside to consensus target.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUWE
40% Buy60% Sell
Avg holding period · 26 Days
XEL
100% Buy0% Sell
Avg holding period · 61 Days

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →

About Xcel Energy Inc

Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan

Read more on XEL →